Page 81 - ITPS-7-2

INNOSC Theranostics and
Pharmacological Sciences Youth brain health check and dysregulation

197. Sambo D, Goldman D. Genetic influences on fetal alcohol doi: 10.1016/j.ajp.2022.103432
spectrum disorder. Genes (Basel). 2023;14(1):195.
207. Henderson EMA, Tappin D, Young D, Favretto D,
doi: 10.3390/genes14010195 Mactier H. Assessing maternal alcohol consumption in
198. Gómez-Medina C, Melo L, Martí-Aguado D, Bataller R. pregnancy: Does phosphatidylethanol measured from
Subclinical versus advanced forms of alcohol-related day 5 newborn blood spot cards have any value? An
liver disease: Need for early detection. Clin Mol Hepatol. observational, population-based study. Arch Dis Child.
2023;29(1):1-15. 2023;108(1):36-41.
doi: 10.3350/cmh.2022.0017 doi: 10.1136/archdischild-2022-324394
199. Kumar P, Sharma A, Kumar D, Sharma L. Use of spectroscopic 208. Syrjanen R, Schumann J, Fitzgerald J, et al. The emerging
methods and their clinical applications in drug abuse: drugs network of Australia - Victoria clinical registry:
A review. Crit Rev Anal Chem. 2023;53(2):360-373. A state-wide illicit substance surveillance and alert
network. Emerg Med Australas. 2023;35(1):82-88.
doi: 10.1080/10408347.2021.1958196
doi: 10.1111/1742-6723.14059
200. Tsai AP, Youngstrom EA, Gadow KD, et al. Diagnostic
accuracy of the Child and adolescent symptom inventory 209. Pautrat M, Renard C, Riffault V, et al. Cross-analyzing
(CASI-4R) substance use subscale in detecting substance addiction specialist and patient opinions and experiences
use disorders in youth. Psychol Assess. 2023;35(2):178-187. about addictive disorder screening in primary care to
identify interaction-related obstacles: A qualitative study.
doi: 10.1037/pas0001182 Subst Abuse Treat Prev Policy. 2023;18(1):12.
201. Patrick ME, Pang YC, Jang BJ, Arterberry BJ, Terry- doi: 10.1186/s13011-023-00522-5
McElrath YM. Alcohol use disorder symptoms reported
during midlife: Results from the monitoring the future 210. Blum K, Han D, Bowirrat A, et al. Genetic addiction risk
study among US adults at modal ages 50, 55, and 60. Subst and psychological profiling analyses for “preaddiction”
Use Misuse. 2023;58(3):380-388. severity index. J Pers Med. 2022;12(11):1772.
doi: 10.1080/10826084.2022.2161826 doi: 10.3390/jpm12111772
202. Ishii A, Sato K, Kusakabe K, Kato N, Wada T. Identification 211. Nutt DJ, Lingford-Hughes A, Erritzoe D, Stokes PR. The
and quantitative analysis of 2-fluoromethamphetamine dopamine theory of addiction: 40 years of highs and lows.
and its metabolites in human urine [published correction Nat Rev Neurosci. 2015;16(5):305-312.
appears in J Anal Toxicol. 2022]. J Anal Toxicol. doi: 10.1038/nrn3939
2023;47(1):59-65.
212. Merians AN, Spiller T, Harpaz-Rotem I, Krystal JH,
doi: 10.1093/jat/bkac026 Pietrzak RH. Post-traumatic stress disorder. Med Clin
203. Greenwald MK, Moses TEH, Lundahl LH, Roehrs TA. North Am. 2023;107(1):85-99.
Anhedonia modulates benzodiazepine and opioid demand doi: 10.1016/j.mcna.2022.04.003
among persons in treatment for opioid use disorder. Front
Psychiatry. 2023;14:1103739. 213. Zhou J, Friedel M, Rosmarin DH, Pirutinsky S. Internet
addiction and the treatment of depression? A prospective
doi: 10.3389/fpsyt.2023.1103739
naturalistic outcome study. Cyberpsychol Behav Soc Netw.
204. Hintze TD, Miller JL, Neely SB, Lim SY, Gupta N, 2023;26(2):121-126.
Johnson PN. Characterization of early versus late opioid doi: 10.1089/cyber.2022.0184
iatrogenic withdrawal syndrome in critically ill children
transitioning from fentanyl -infusions to methadone. 214. Ray LA, Nieto SJ, Grodin EN. Translational models
J Opioid Manag. 2023;19(1):43-56. of addiction phenotypes to advance addiction
pharmacotherapy. Ann N Y Acad Sci. 2023;1519(1):118-128.
doi: 10.5055/jom.2023.0758
doi: 10.1111/nyas.14929
205. Dobson MS, Blackhall LJ. Letter to the Editor: Universal
screening for substance use disorder in a palliative care 215. Ghosh A, Sharma N, Noble D, et al. Predictors of treatment
clinic: Results and longitudinal outcomes for patients with completion in an inpatient substance use treatment service
cancer. J Palliat Med. 2023;26(2):160-161. in India. J Addict Med. 2023;17(2):e101-e109.
doi: 10.1089/jpm.2022.0502 doi: 10.1097/ADM.0000000000001076
206. Sharma K, Ghosh A, Krishnan NC, et al. Digital screening 216. Osińska M, Towpik I, Sanchak Y, Franek E, Śliwczyński A,
and brief intervention for illicit drug misuse in college Walicka M. Cost of surgical treatment of obesity and
students: A mixed methods, pilot, cluster, randomized trial its impact on healthcare expense-nationwide data
from India. Asian J Psychiatr. 2023;81:103432. from a polish registry. Int J Environ Res Public Health.

Volume 7 Issue 2 (2024) 21 doi: 10.36922/itps.1472